Booz Allen Hamilton Holding Corporation · BAH · FY2027 Q2 · Calendar Q4 2026

Booz Allen pairs modest revenue decline with stronger defense-tech focus

The current analysis supports a constructive but qualified outlook: resilient national-security demand, cyber and defense-tech expansion, and a large backlog provide support, while modest revenue decline, civil weakness, and federal funding uncertainty temper the case for sustained growth.

Why did BAH fall 0.3% after beating EPS estimates in FY2027 Q2?

Research this report with FN2. Free to start; review your question before sending.

Reported Before market openNYSEIndustrials $10.03B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.76 Consensus $1.48
EPS surprise +18.9% Reported versus consensus
Reported revenue $2.78B Consensus $2.81B
Revenue surprise -1.1% Reported versus consensus
Check the math in the surprise calculator >

Market reaction

prior-close to event-session close
Stock move -0.3% Event window
SPY move -0.5% Same window
Abnormal move +0.2% Stock minus SPY
Volume 2.1× Versus trailing sessions
Subsequent drift +6.4% Up to 20 sessions
BAHSPY benchmark

Ask FN2 about BAH FY2027 Q2

Choose a question to continue your research

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Transcript intelligence

What changed

Relative to the prior quarter, the company highlighted the launch of Velox and Guile, completed the Ultra I&C Mission Solutions acquisition, and described a stronger defense-tech product focus. The current analysis also reports FY27 adjusted EBITDA and EPS guidance with a higher lower end, while revenue growth expectations remain modest.

Guidance delta

Management maintained FY27 revenue guidance and raised the lower end of adjusted EBITDA and EPS guidance, according to the current transcript analysis.

Key takeaways

  • Revenue declined modestly, while ex-billable performance and national-security growth remained stronger.
  • Management identified cyber, defense technology, Velox, Guile, and the Ultra acquisition as key growth drivers.
  • A $41 billion backlog, including $5.7 billion funded, supports the outlook, but federal budget uncertainty remains.
  • Management expects outcome-based and fixed-price contracting to improve margins over time.

Management priorities

  • Scale and commercialize the Velox Agentic Cyber suite and Guile counter-SI product.
  • Integrate Ultra I&C Mission Solutions into the defense-technology business.
  • Continue investment in SI, quantum, 6G, and other emerging technology platforms.
  • Expand outcome-based contracting while maintaining disciplined capital deployment.

Follow BAH with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
BAH EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q1 '25 estimate $1.52 Q1 '25 actual $1.38, miss Q2 '25 estimate $1.48 Q2 '25 actual $1.81, beat Q1 '26 estimate $1.45 Q1 '26 actual $1.48, beat Q2 '26 estimate $1.51 Q2 '26 actual $1.49, miss Q3 '26 estimate $1.32 Q3 '26 actual $1.77, beat Q4 '26 estimate $1.32 Q4 '26 actual $1.78, beat Q1 '27 estimate $1.49 Q1 '27 actual $1.81, beat Q2 '27 estimate $1.48 Q2 '27 actual $1.76, beat Q3 '27 estimate $1.47 Q4 '27 estimate $1.57 Q1 '28 estimate $1.70 Q2 '28 estimate $1.65
Show 2 more >

Analyst Consensus ?

ConsensusHold23 ratings
Bullish1252.2%
Neutral834.8%
Bearish313.0%

Analyst 52W Price Targets

$81.02Current
$65Low
$102.65Average
$174High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Citigroup Neutral NeutralMaintainNov 10, 2026
TD Cowen Buy HoldUpgradeOct 26, 2026
BNP Paribas Neutral NeutralMaintainOct 26, 2026
Truist Securities Buy HoldUpgradeOct 8, 2026
Jefferies Hold HoldMaintainOct 7, 2026
UBS Neutral NeutralMaintainJul 27, 2026
Cantor Fitzgerald Overweight OverweightMaintainJul 23, 2026
B of A Securities Underperform UnderperformMaintainJul 20, 2026
Goldman Sachs Sell SellMaintainJul 14, 2026
Stifel Buy HoldUpgradeMay 26, 2026
JP Morgan Underweight UnderweightMaintainMay 26, 2026
William Blair Outperform Market PerformUpgradeJul 22, 2025
Barclays Equal Weight Equal WeightMaintainMay 28, 2025
Wells Fargo Overweight OverweightMaintainMay 27, 2025
Raymond James Outperform Market PerformUpgradeFeb 3, 2025
Morgan Stanley Overweight OverweightMaintainFeb 2, 2023
Cowen & Co. Outperform OutperformMaintainOct 31, 2022
Credit Suisse Outperform OutperformMaintainNov 2, 2020
SunTrust Robinson Humphrey Buy BuyMaintainApr 14, 2020
Vertical Research Hold BuyDowngradeJul 9, 2018
Bank of America Neutral NeutralMaintainJun 8, 2018
Drexel Hamilton Hold BuyDowngradeJun 16, 2017
Stifel Nicolaus Buy BuyMaintainNov 26, 2014
Show less

Named analyst price targets

Upside is calculated against the persisted current price $81.02. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSAnalyst unavailable$86$82.3 +6.1%Oct 26, 2026
TD CowenGautam Khanna$95$83.36 +17.3%Oct 26, 2026
National BankAnalyst unavailable$95$78.32 +17.3%Oct 26, 2026
Bank of America SecuritiesAnalyst unavailable$68$78.32 -16.1%Oct 26, 2026
Truist FinancialTobey Sommer$85$68.69 +4.9%Oct 8, 2026
JefferiesSheila Kahyaoglu$75$67.24 -7.4%Oct 7, 2026
JefferiesAnalyst unavailable$80$75.65 -1.3%Sep 1, 2026
UBSGavin Parsons$78$72.35 -3.7%Jul 27, 2026
Cantor FitzgeraldAnalyst unavailable$140$66.13 +72.8%Jul 23, 2026
Goldman SachsNoah Poponak$65$64.8 -19.8%Jul 14, 2026
Truist FinancialAnalyst unavailable$70$63.41 -13.6%Jul 10, 2026
BNP ParibasAnalyst unavailable$80$80.26 -1.3%May 27, 2026
UBSGavin Parsons$83$79 +2.4%May 26, 2026
Stifel NicolausAnalyst unavailable$110$78.68 +35.8%May 26, 2026
JefferiesAnalyst unavailable$85$74.95 +4.9%May 11, 2026
UBSAnalyst unavailable$97$92.84 +19.7%Jan 27, 2026
D.A. DavidsonJeff Rulis$81$92.75 -0.0%Jan 27, 2026
Stifel NicolausAnalyst unavailable$115$102.23 +41.9%Jan 26, 2026
Truist FinancialAnalyst unavailable$98$102.23 +21.0%Jan 23, 2026
JefferiesQ3 EPS$95$86.85 +17.3%Dec 18, 2025
UBSAnalyst unavailable$93$90.22 +14.8%Oct 27, 2025
Goldman SachsNoah Poponak$80$91.4 -1.3%Oct 27, 2025
Stifel NicolausAnalyst unavailable$106$91.4 +30.8%Oct 24, 2025
Truist FinancialTobey Sommer$90$91.4 +11.1%Oct 24, 2025
UBSGavin Parsons$119$109.44 +46.9%Jul 28, 2025
Stifel NicolausJonathan Siegmann$119$109.38 +46.9%Jul 28, 2025
UBSGavin Parsons$159$148.18 +96.2%Dec 2, 2024
JefferiesSheila Kahyaoglu$190$182.62 +134.5%Nov 4, 2024
Truist FinancialTobey Sommer$165$156.44 +103.7%Sep 5, 2024
Wells FargoMatthew Akers$165$139.84 +103.7%Jul 29, 2024
Goldman SachsGavin Parsons$174$139.84 +114.8%Jul 26, 2024
Truist FinancialTobey Sommer$140$139.84 +72.8%Jul 26, 2024
CFRACaydee Blankenship$160$139.84 +97.5%Jul 26, 2024
JefferiesSheila Kahyaoglu$185$154.6 +128.3%May 29, 2024
Wells FargoMatthew Akers$169$158.51 +108.6%May 28, 2024
Truist FinancialTobey Sommer$160$158.51 +97.5%May 24, 2024
Truist FinancialTobey Sommer$145$152.36 +79.0%May 24, 2024
JefferiesSheila Kahyaoglu$180$148.7 +122.2%May 14, 2024
Truist FinancialTobey Sommer$120$120.45 +48.1%Jul 31, 2023
Stifel NicolausBert Subin$125$112.79 +54.3%Jul 13, 2023
Morgan StanleyMatthew Sharpe$116$89.85 +43.2%May 26, 2023
Morgan StanleyAnalyst unavailable$118$104.58 +45.6%Jan 3, 2023
Morgan StanleyAnalyst unavailable$110$105.32 +35.8%Dec 14, 2022
Raymond JamesBrian Gesuale$96$84.76 +18.5%May 25, 2022
Goldman SachsGavin Parsons$102$87.01 +25.9%Apr 19, 2022
Stifel NicolausBert Subin$96$86.68 +18.5%Mar 20, 2022
Bank of America SecuritiesRonald Epstein$90$83.49 +11.1%Mar 14, 2022
BarclaysDavid Strauss$105$75.25 +29.6%Jan 30, 2022
Morgan StanleyMatthew Sharpe CFA$98$86.92 +21.0%Nov 2, 2021
Show less

Track every rating change on BAH the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Booz Allen Hamilton Holding Corporation (BAH) operates as a prominent consulting and technology firm, offering a diverse range of services to governmental bodies, commercial enterprises, and non-profit organizations both domestically and internationally. Their core offerings encompass strategic management and technology advisory, with a focus on areas like business strategy, human resources, and operational efficiency across various sectors. A significant aspect of their work involves advanced analytics.…

Historical context

All BAH earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the BAH recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-10-23T15:03:39.210998+00:00
  2. FN2 earnings calendar · 2026-10-27T01:23:15.065758+00:00
  3. Polygon adjusted daily market bars · 2026-10-27T01:30:41.875324+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-27T01:30:41.872434+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-27. For educational purposes only; not investment advice.